DE60221787D1 - Zusammensetzungen mit schneller Freisetzung enthaltend Cefuroxime Axetil - Google Patents

Zusammensetzungen mit schneller Freisetzung enthaltend Cefuroxime Axetil

Info

Publication number
DE60221787D1
DE60221787D1 DE60221787T DE60221787T DE60221787D1 DE 60221787 D1 DE60221787 D1 DE 60221787D1 DE 60221787 T DE60221787 T DE 60221787T DE 60221787 T DE60221787 T DE 60221787T DE 60221787 D1 DE60221787 D1 DE 60221787D1
Authority
DE
Germany
Prior art keywords
fast release
compositions containing
release compositions
cefuroxime axetil
containing cefuroxime
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60221787T
Other languages
English (en)
Other versions
DE60221787T2 (de
Inventor
Evangelos Karavas
Evangelos Kotzagiorgis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orbus Pharma Inc
Original Assignee
Orbus Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orbus Pharma Inc filed Critical Orbus Pharma Inc
Application granted granted Critical
Publication of DE60221787D1 publication Critical patent/DE60221787D1/de
Publication of DE60221787T2 publication Critical patent/DE60221787T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DE60221787T 2002-03-04 2002-03-04 Zusammensetzungen mit schneller Freisetzung enthaltend Cefuroxime Axetil Expired - Fee Related DE60221787T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02386005A EP1342470B1 (de) 2002-03-04 2002-03-04 Zusammensetzungen mit schneller Freisetzung enthaltend Cefuroxime Axetil

Publications (2)

Publication Number Publication Date
DE60221787D1 true DE60221787D1 (de) 2007-09-27
DE60221787T2 DE60221787T2 (de) 2008-06-05

Family

ID=27741258

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60221787T Expired - Fee Related DE60221787T2 (de) 2002-03-04 2002-03-04 Zusammensetzungen mit schneller Freisetzung enthaltend Cefuroxime Axetil

Country Status (7)

Country Link
EP (1) EP1342470B1 (de)
AT (1) ATE369842T1 (de)
CA (1) CA2420712C (de)
DE (1) DE60221787T2 (de)
DK (1) DK1342470T5 (de)
ES (1) ES2291433T3 (de)
PT (1) PT1342470E (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE042611T2 (hu) † 2011-07-28 2019-07-29 Rigel Pharmaceuticals Inc Új (trimetoxifenilamino)pirimidinil készítmények
WO2013109206A1 (en) * 2012-01-18 2013-07-25 Mahmut Bilgic Tablet formulations comprising cefuroxime
CN102641247B (zh) * 2012-04-20 2013-09-25 吉林敖东延边药业股份有限公司 泡腾剂酸碱中和制粒方法
CN102697747A (zh) * 2012-06-13 2012-10-03 广州南新制药有限公司 一种头孢呋辛酯的分散片
CN106109433A (zh) * 2016-08-10 2016-11-16 瑞阳制药有限公司 头孢呋辛酯薄膜衣片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
CA2239331C (en) * 1998-05-29 1999-11-30 Bernard Charles Sherman Pharmaceutical tablets comprising cefuroxime axetil

Also Published As

Publication number Publication date
CA2420712A1 (en) 2003-09-04
ES2291433T3 (es) 2008-03-01
EP1342470A1 (de) 2003-09-10
DK1342470T5 (da) 2008-04-07
EP1342470B1 (de) 2007-08-15
CA2420712C (en) 2009-07-07
ATE369842T1 (de) 2007-09-15
DK1342470T3 (da) 2007-12-27
PT1342470E (pt) 2007-11-13
DE60221787T2 (de) 2008-06-05

Similar Documents

Publication Publication Date Title
WO2006069236A3 (en) Sustained release tooth whitening formulations and systems
DE60222415D1 (de) Resorbierbare polymerzusammensetzungen
DE60334379D1 (de) Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung
RS54275B1 (sr) Vodeni 2,6-diizopropilfenol farmaceutski sastavi
AR033395A1 (es) Un articulo endurecido, un metodo para formar un articulo endurecido y un articulo producido por el metodo.
ATE328958T1 (de) Hdpe polymerzusammensetzung
GT200400175A (es) Rapamicina amorfa 42-ester con 3-hidroxi-2-(hidroximetil)-2-acido metilpropionico y sus composiciones farmaceuticas
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
WO2003045878A3 (en) 2,w-diaminocarboxylic acid compounds
EP1431363A3 (de) Schmelzhaftkleber auf Basis von Acrylatblockcopolymeren.
MXPA05007165A (es) Reactivos polimericos que comprnden una cetona o un grupo funcional relacionado.
SE0201659D0 (sv) Modified release pharmaceutical formulation
BR0110067A (pt) Composição polimérica para canos
IL171875A0 (en) Pioglitazone salts,such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
AU2002225369A1 (en) Photobase generators, curable compositions prepared by using the same and process of curing
DE50210465D1 (de) Stabilisierte thermoplastische formmassen
WO2002064574A3 (en) Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
ATE528009T1 (de) Reepithelialisierende pharmazeutische zusammensetzungen, die xanthangummi enthalten
DE60210598D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
FR2804125B1 (fr) Liant bitumineux, compositions coloree obtenue a partir de ce liant et leurs applications
DE60221787D1 (de) Zusammensetzungen mit schneller Freisetzung enthaltend Cefuroxime Axetil
DE602004019083D1 (de) Sauerstoffbarriereformulierungen
TR200102566T2 (tr) Kontrollü salınan betahistin bileşimleri.
BRPI0406734A (pt) Composição termiticida, e, método para controlar térmitas
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee